Diseases affecting the retina, like AMD, and diabetic retinopathy, are treated using anti-VEGF solutions like Lucentis® (Ranibizumab) and Avestin® (Bevacizumab) using this route, and steroids like solutions (Kenalog-40), depots (suspensions and implants, e.g., TRIESENCETM and OZURDEX®) for management of posterior uveitis, exudative macular degeneration, macular edema (diabetic and vasculo-occlusive) and pseudophakic cystoid macular edema leading to improvement of symptoms and prevention of vision impairment [121]. The gene discussed is VEGFA; the disease is age-related macular degeneration.